Page last updated: 2024-08-26

arsenic and Leukemia, Myeloid, Acute, M4

arsenic has been researched along with Leukemia, Myeloid, Acute, M4 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowen, D; Burnett, AK; Cahalin, P; Craig, J; Hills, RK; Hunter, A; Kell, J; McMullin, MF; Milligan, D; Russell, N; Wheatley, K; Yin, J1
Andreeff, M; Cheng, X; Freireich, EJ; Gao, MZ; Golemovic, M; Kantarjian, HM; Quintás-Cardama, A; Verstovsek, S; Zingaro, R1
Farhat, M; Venugopal, P1
Zhang, Z1

Reviews

2 review(s) available for arsenic and Leukemia, Myeloid, Acute, M4

ArticleYear
Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation.
    Clinical advances in hematology & oncology : H&O, 2007, Volume: 5, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cranial Irradiation; Daunorubicin; Ear Neoplasms; Humans; Injections, Spinal; Leukemia, Myelomonocytic, Acute; Male; Oxides; Radiography; Remission Induction; Sarcoma, Myeloid; Tretinoin

2007
[Progresses in the study of hematology in China, 1997].
    Zhonghua yi xue za zhi, 1997, Volume: 77, Issue:12

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Oxides; Thrombophlebitis

1997

Trials

1 trial(s) available for arsenic and Leukemia, Myeloid, Acute, M4

ArticleYear
The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome.
    Leukemia, 2011, Volume: 25, Issue:7

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Comorbidity; Cytarabine; Disease-Free Survival; Early Termination of Clinical Trials; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Oxides; Remission Induction; Treatment Outcome

2011

Other Studies

1 other study(ies) available for arsenic and Leukemia, Myeloid, Acute, M4

ArticleYear
The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells.
    Anticancer research, 2012, Volume: 32, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 9; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Female; HL-60 Cells; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Mice; Oncogene Proteins, Fusion; Oxides; Oxygen

2012